1 week Ago By Defense World Staff
Corebridge Financial Inc. decreased its holdings in Bath & Body Works, Inc. ( NYSE:BBWI – Free Report ) by 11.
5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,249 shares of the company’s stock after selling 1,198 shares during the quarter. Corebridge Financial Inc.
’s holdings in Bath & Body Works were worth $359,000 at the end of the most recent quarter. Other hedge funds have also recently made changes to their positions in the company. Golden State Wealth Management LLC purchased a new position in Bath & Body Works in the fourth quarter worth about $26,000.
SRS Capital Advisors Inc. boosted its holdings in shares of Bath & Body Works by 99.7% in the fourth quarter.
SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after buying an additional 329 shares during the last quarter. UMB Bank n.
a. grew its position in Bath & Body Works by 58.8% during the fourth quarter.
UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares during the period.
Lindbrook Capital LLC increased its holdings in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares during the last quarter.
Finally, Wilmington Savings Fund Society FSB bought a new position in Bath & Body Works in the third quarter worth approximately $39,000. 95.14% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In A number of equities research analysts have recently issued reports on the stock. Argus reissued a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Barclays decreased their price objective on Bath & Body Works from $43.
00 to $38.00 and set an “equal weight” rating on the stock in a research note on Monday, March 3rd. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $42.
00 to $48.00 in a research note on Friday, January 10th. TD Cowen raised their target price on shares of Bath & Body Works from $42.
00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, Robert W.
Baird upped their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research report on Friday, February 28th.
Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $44.
06. Bath & Body Works Price Performance NYSE BBWI opened at $30.06 on Thursday.
Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.
99. The business has a 50 day simple moving average of $33.44 and a two-hundred day simple moving average of $34.
03. The stock has a market capitalization of $6.44 billion, a PE ratio of 7.
33, a P/E/G ratio of 0.92 and a beta of 1.69.
Bath & Body Works ( NYSE:BBWI – Get Free Report ) last announced its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.
04 by $0.05. Bath & Body Works had a net margin of 12.
43% and a negative return on equity of 44.03%. The company had revenue of $2.
79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. On average, analysts anticipate that Bath & Body Works, Inc.
will post 3.3 EPS for the current fiscal year. Bath & Body Works Announces Dividend The business also recently declared a quarterly dividend, which was paid on Friday, March 7th.
Investors of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st.
This represents a $0.80 annualized dividend and a yield of 2.66%.
Bath & Body Works’s dividend payout ratio is currently 21.98%. Bath & Body Works announced that its board has authorized a stock buyback plan on Thursday, February 27th that authorizes the company to buyback $500.
00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.4% of its stock through open market purchases.
Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued. Bath & Body Works Profile ( Free Report ) Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Recommended Stories Five stocks we like better than Bath & Body Works What Do S&P 500 Stocks Tell Investors About the Market? Quantum Computing: The $6.
5 Billion Opportunity You Can’t Ignore Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance Are Tariffs Threatening Disney’s Comeback Story? How to Find Undervalued Stocks Is Alphabet a Generational Buying Opportunity at These Levels? Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter ..
